Results
|
|
7261.
|
|
|
|
7262.
|
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer. [electronic resource] by
- Somlo, G
- Martel, C L
- Lau, S K
- Frankel, P
- Ruel, C
- Gu, L
- Hurria, A
- Chung, C
- Luu, T
- Morgan, R
- Leong, L
- Koczywas, M
- McNamara, M
- Russell, C A
- Kane, S E
Producer: 20120515
In:
Breast cancer research and treatment vol. 131
Availability: No items available.
|
|
|
7263.
|
Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID? [electronic resource] by
- Hodgkinson, Victoria C
- ELFadl, Dalia
- Agarwal, Vijay
- Garimella, Veerabhadram
- Russell, Charlotte
- Long, Ervine D
- Fox, John N
- McManus, Penelope L
- Mahapatra, Tapan K
- Kneeshaw, Peter J
- Drew, Philip J
- Lind, Michael J
- Cawkwell, Lynn
Producer: 20120622
In:
Journal of proteomics vol. 75
Availability: No items available.
|
|
|
7264.
|
Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer. [electronic resource] by
- Camerini, Andrea
- Donati, Sara
- Viacava, Paolo
- Siclari, Olimpia
- Puccetti, Cheti
- Tartarelli, Gianna
- Valsuani, Chiara
- De Luca, Filomena
- Martini, Leonardo
- Cavazzana, Andrea
- Amoroso, Domenico
Producer: 20110610
In:
Journal of experimental & clinical cancer research : CR vol. 30
Availability: No items available.
|
|
|
7265.
|
Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trial. [electronic resource] by
- Hamberg, Paul
- Bos, Monique M E M
- Braun, Hans J J
- Stouthard, Jacqueline M L
- van Deijk, Gert A
- Erdkamp, Frans L G
- van der Stelt-Frissen, Iris N
- Bontenbal, Marijke
- Creemers, Geert-Jan M
- Portielje, Johanneke E A
- Pruijt, Johannes F M
- Loosveld, Olaf J L
- Smit, Willem M
- Muller, Erik W
- Schmitz, Paul I M
- Seynaeve, Caroline
- Klijn, Jan G M
Producer: 20110927
In:
Clinical breast cancer vol. 11
Availability: No items available.
|
|
|
7266.
|
Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group. [electronic resource] by
- Califano, Raffaele
- Griffiths, Richard
- Lorigan, Paul
- Ashcroft, Linda
- Taylor, Paul
- Burt, Paul
- Lee, Lip
- Chittalia, Abbas
- Harris, Margaret
- Faivre-Finn, Corinne
- Thatcher, Nick
- Blackhall, Fiona
Producer: 20111128
In:
Lung cancer (Amsterdam, Netherlands) vol. 73
Availability: No items available.
|
|
|
7267.
|
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study. [electronic resource] by
- Chen, Jianghao
- Yao, Qing
- Li, Dong
- Zhang, Juliang
- Wang, Ting
- Yu, Ming
- Zhou, Xiaodong
- Huan, Yi
- Wang, Jing
- Wang, Ling
Producer: 20150127
In:
BMC cancer vol. 13
Availability: No items available.
|
|
|
7268.
|
|
|
|
7269.
|
|
|
|
7270.
|
|
|
|
7271.
|
Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy. [electronic resource] by
- Tan, Q
- Joshua, A M
- Saggar, J K
- Yu, M
- Wang, M
- Kanga, N
- Zhang, J Y
- Chen, X
- Wouters, B G
- Tannock, I F
Producer: 20150430
In:
British journal of cancer vol. 112
Availability: No items available.
|
|
|
7272.
|
Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. [electronic resource] by
- Li, Shau-Hsuan
- Lin, Wei-Che
- Huang, Tai-Lin
- Chen, Chang-Han
- Chiu, Tai-Jan
- Fang, Fu-Min
- Huang, Wan-Ting
- Hsu, Cheng-Ming
- Luo, Sheng-Dean
- Lai, Chi-Chih
- Su, Yan-Ye
- Chuang, Hui-Ching
- Chien, Chih-Yen
Producer: 20180227
In:
Head & neck vol. 38 Suppl 1
Availability: No items available.
|
|
|
7273.
|
|
|
|
7274.
|
|
|
|
7275.
|
|
|
|
7276.
|
|
|
|
7277.
|
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401. [electronic resource] by
- Oh, In-Jae
- Kim, Kyu-Sik
- Kim, Young-Chul
- Ban, Hee-Jung
- Kwon, Yong-Soo
- Kim, Yu-Il
- Lim, Sung-Chul
- Chung, Woong-Ki
- Nam, Taek-Keun
- Song, Joo-Young
- Yoon, Mee-Sun
- Ahn, Sung-Ja
Producer: 20140130
In:
Cancer chemotherapy and pharmacology vol. 72
Availability: No items available.
|
|
|
7278.
|
|
|
|
7279.
|
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma. [electronic resource] by
- Park, Inkeun
- Ryu, Min-Hee
- Choi, Yoon Hee
- Kang, Hyo Jeong
- Yook, Jeong Hwan
- Park, Young Soo
- Kim, Hyun Jin
- Jung, Hwoon-Yong
- Lee, Gin Hyug
- Kim, Kab Choong
- Kim, Byung Sik
- Kang, Yoon-Koo
Producer: 20140428
In:
Cancer chemotherapy and pharmacology vol. 72
Availability: No items available.
|
|
|
7280.
|
|